| Autor: |
Marino-Vázquez LA; Department of Nephrology and Mineral Metabolism, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga 15, Seccion XVI, Tlalpan, Mexico City, Mexico., Leyva S, Alberú J, Morales-Buenrostro LE |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical transplants [Clin Transpl] 2010, pp. 363-7. |
| Abstrakt: |
Highly sensitized patients represent a challenge in all transplant programs. The use of bortezomib in combination with other strategies could be a real option for some patients. Unfortunately, one single cycle of four doses of bortezomib with 3 PP sessions may not be sufficient. With all the agents available to use in desensitization it is still not clear what is the best combination or who are the best candidates. We need more time and experience with its use to identify which patients could be the best candidate to receive it for desensitization. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
